Literature DB >> 32375503

Response by Hoque et al to Letter Regarding Article, "SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation".

Laboni Hoque1, David D McManus1,2, Alok Kapoor1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32375503      PMCID: PMC7735371          DOI: 10.1161/CIRCOUTCOMES.120.006671

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


× No keyword cloud information.
  3 in total

1.  Mobile Health (mHealth) technology for improved screening, patient involvement and optimising integrated care in atrial fibrillation: The mAFA (mAF-App) II randomised trial.

Authors:  Yutao Guo; Deirdre A Lane; Liming Wang; Yundai Chen; Gregory Y H Lip
Journal:  Int J Clin Pract       Date:  2019-06-03       Impact factor: 2.503

2.  SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation.

Authors:  Alok Kapoor; Azraa Amroze; Fatima Vakil; Sybil Crawford; Jacqueline Der; Jomol Mathew; Eric Alper; Dinesh Yogaratnam; Saud Javed; Rasha Elhag; Abraham Lin; Siddhartha Narayanan; Donna Bartlett; Ahmed Nagy; Bevin Kathleen Shagoury; Michael A Fischer; Kathleen M Mazor; Jane S Saczynski; Jeffrey M Ashburner; Renato Lopes; David D McManus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-02-17

3.  Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.

Authors:  Michael W Cullen; Sunghee Kim; Jonathan P Piccini; Jack E Ansell; Greg C Fonarow; Elaine M Hylek; Daniel E Singer; Kenneth W Mahaffey; Peter R Kowey; Laine Thomas; Alan S Go; Renato D Lopes; Paul Chang; Eric D Peterson; Bernard J Gersh
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.